Prader-Willi Syndrome Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight

(Albany, USA) DelveInsight's, "Prader-Willi Syndrome Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Prader-Willi Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Prader Willi Syndrome Research. Learn more about our innovative pipeline today! @ Prader Willi Syndrome Pipeline Outlook- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the Prader Willi Syndrome Pipeline Report
• In November 2024:- Harmony Biosciences LLC- A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome. The study will consist of an up to 45-day Screening/Baseline Period, a Double-Blind Treatment Period, and an optional Open-Label Extension Period.
• In November 2024:- ACADIA Pharmaceuticals- A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome. This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study comparing carbetocin nasal spray 3.2 mg TID with placebo (matched placebo nasal spray TID) in subjects with PWS.
• DelveInsight's Prader Willi Syndrome pipeline report depicts a robust space with 18+ active players working to develop 18+ pipeline therapies for Prader Willi Syndrome treatment.
• The leading Prader Willi Syndrome Companies such as Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
• Promising Prader Willi Syndrome Therapies such as DCCR, ARD-101, Carbetocin, and others.

Stay informed about the cutting-edge advancements in Prader Willi Syndrome treatments. Download for updates and be a part of the revolution in care @ Prader Willi Syndrome Clinical Trials Assessment- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Prader Willi Syndrome Emerging Drugs Profile

• Diazoxide choline controlled release (DCCR): Soleno Therapeutics
Diazoxide choline controlled-release tablet is a novel, proprietary extended-release, crystalline salt formulation of diazoxide, which is administered once-daily. The parent molecule, diazoxide, has been used for decades in thousands of patients in a few rare diseases in neonates, infants, children and adults, but has not been approved for use in PWS. Soleno conceived of and established extensive patent protection on the therapeutic use of diazoxide and DCCR in patients with PWS. The DCCR development program is supported by data from five completed Phase I clinical studies in healthy volunteers and three completed Phase II clinical studies, one of which was in PWS patients. In the PWS Phase II study, DCCR showed promise in addressing hyperphagia, the hallmark symptom of PWS, as well as several other symptoms such as aggressive/destructive behaviors, fat mass and abnormal lipid profiles. It is currently in phase III stage of development.

• Intranasal carbetocin (LV-101): Levo Therapeutics
Intranasal carbetocin is similar to the naturally-occurring hormone oxytocin, but with greater selectivity for the effect of interest - stimulation of oxytocin receptors. These receptors are involved in the regulation of both social-emotional and feeding behaviors. In July 2022, company announced that the U.S. Food and Drug Administration (FDA) had granted Priority Review for its New Drug Application (NDA) for LV-101 (intranasal carbetocin) as a treatment for hyperphagia and behavioral distress associated with PWS.

Learn more about Prader Willi Syndrome Drugs opportunities in our groundbreaking Prader Willi Syndrome Research and development projects @ Prader Willi Syndrome Unmet Needs- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Prader Willi Syndrome Companies
Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.

Prader-Willi Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical.
• Molecule Type

Prader Willi Syndrome Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Discover the latest advancements in Prader Willi Syndrome treatment by visiting our website. Stay informed about how we're transforming the future of disease @ Prader Willi Syndrome Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Prader Willi Syndrome Pipeline Report
• Coverage- Global
• Prader Willi Syndrome Companies- Soleno Therapeutics, Levo Therapeutics, Inversago Pharma, Saniona, LG Life Sciences, GLWL Research, OptiNose, Larimar Therapeutics, Helsinn, ConSynance Therapeutics, Neuren Pharmaceuticals, Radius Health, Rhythm, Tonix Pharmaceuticals, and others.
• Prader Willi Syndrome Therapies- DCCR, ARD-101, Carbetocin, and others.
• Prader Willi Syndrome Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Prader Willi Syndrome Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Prader Willi Syndrome Pipeline on our website @ Prader Willi Syndrome Emerging Drugs and Companies- https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
1. Introduction
2. Executive Summary
3. Prader-Willi Syndrome: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. Diazoxide choline controlled release (DCCR): Soleno Therapeutics
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. Tesomet: Saniona
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I)
13. INV 101: Inversago Pharma
14. Drug profiles in the detailed report…..
15. Preclinical and Discovery Stage Products
16. TNX-2900: Tonix Pharmaceuticals
17. Drug profiles in the detailed report…..
18. Inactive Products
19. Prader-Willi Syndrome Key Companies
20. Prader-Willi Syndrome Key Products
21. Prader-Willi Syndrome- Unmet Needs
22. Prader-Willi Syndrome- Market Drivers and Barriers
23. Prader-Willi Syndrome- Future Perspectives and Conclusion
24. Prader-Willi Syndrome Analyst Views
25. Prader-Willi Syndrome Key Companies
26. Appendix

Trending Reports:
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Arthroscopic Shavers Market: https://www.delveinsight.com/report-store/arthroscopic-shavers-market
• Aspergillosis Market: https://www.delveinsight.com/report-store/aspergillosis-market
• Atrophic Vaginitis Market: https://www.delveinsight.com/report-store/atrophic-vaginitis-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Autonomic Dysfunction Market: https://www.delveinsight.com/report-store/dysautonomia-autonomic-dysfunction-market
• Autosomal Recessive Congenital Ichthyosis Market Size: https://www.delveinsight.com/report-store/congenital-ichthyosis-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/bile-duct-cancer-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Bradycardia Treatment Devices Market: https://www.delveinsight.com/report-store/bradycardia-treatment-devices-market
• Car T Therapy For Acute Lymphoblastic Leukemia All Market: https://www.delveinsight.com/report-store/car-t-cell-therapy-for-acute-lymphoblastic-leukemia-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Checkpoint Inhibitor Refractory Cancer Market: https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market
• Chondrosarcoma Market: https://www.delveinsight.com/report-store/chondrosarcoma-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Chronic Rhinosinusitis Phenotype With Nasal Polyps Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-phenotype-with-nasal-polyps-market-insight
• Clostridium Difficile Infections Cdi Market: https://www.delveinsight.com/report-store/clostridium-difficile-infections-clostridium-difficile-associated-disease-market
• Conference Coverage Services: https://www.delveinsight.com/consulting/conference-coverage-services
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Deep Vein Thrombosis Market: https://www.delveinsight.com/report-store/deep-vein-thrombosis-market
• Dermal Mycosis Market: https://www.delveinsight.com/report-store/dermal-mycosis-pipeline-insight
• Diabetic Nephropathy Market: https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.